ATAI Life Sciences is a clinical-stage biopharmaceutical company focused on developing therapies that address mental health disorders. The company operates as a platform company that leverages its pipeline and partnerships to advance innovative treatments.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!